Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/15/2018
Type 1 Diabetes on the Rise in China, Most New Cases in Adults
12/21/2017
vTv Therapeutics Licenses GLP-1r Agonist Diabetes Program to Huadong P...
12/21/2017
Fast Rising Price of Chinese APIs Puts Pressure on Bottom Lines of Ind...
11/8/2017
CFDA Suspends Import of Rabeprazole API from India for Chinese GMP Iss...
10/30/2017
Sumitomo Dainippon and Poxel Enter Partnership for Novel Diabetes Drug...
10/10/2017
Indian and Chinese Drugmakers Dominate Asia Power Ranking
9/27/2017
CFDA Approves Boehringer/Lilly's Jardiance (Empagliflozin) for Type 2 ...
9/27/2017
Novo Nordisk Diabetes Drug Approved in China
9/22/2017
Novo Nordisk Eyes Growth GLP-1 Diabetes Drugs in Untapped China
9/14/2017
China Sets Up The Changing Diabetes Foundation with Help of Novo Nordi...
7/31/2017
India Hesitates About Fosun's Acquisition of Gland Pharma
7/5/2017
Biological E Licenses Two of Takeda's Vaccines for India and China
6/28/2017
WSJ: Novo Nordisk Wagers Sales Growth Will Offset Price Cuts In China
6/28/2017
New Survey: China Faces the Largest Diabetes Epidemic in the World
6/20/2017
China Establishes National Center for Children's Health
5/18/2017
CFDA Issues Technical Guidelines on Extrapolation of Adult Drug Usage ...
5/16/2017
A Dual-Functional GLP-1 Analogue May Improve Insulin Sensitivity and H...
5/16/2017
3SBio Enters Strategic Alliance with Eli Lilly for Insulin Products
5/15/2017
China Introduces Second Batch of Encouraged Pediatric Drug Products
5/5/2017
Uni-Bio Science Launches Best-in-Class Oral Anti-Diabetic Drug Mitigli...
4/27/2017
India to Make Key APIs to Reduce Dependence on China
4/13/2017
Chinese Journal Publishes the Findings of Largest Phase IV Trial of Ty...
4/5/2017
China Grants Approval to Boehringer/Lilly Drug for Diabetes
3/29/2017
India Clears Fosun's Acquisition of Gland Pharma
3/13/2017
CFDA Approves China's First SGLT2 Inhibitor for Type 2 Diabetes
3/6/2017
CDE Solicits Comments for Preclinical Safety Studies of Pediatric Drug...
2/16/2017
India Pressures CFDA to Act and Restore Supply of Rare Disease API
1/17/2017
The Diabetes Epidemic in China: An Integrated Review of National Surve...
12/15/2016
Pfizer Enters R&D Partnership with PegBio for Select Diabetes Drug...
11/14/2016
India Puts Chinese APIs on Radar over Quality Concerns
Page:
7
/
16
Total number of articles:
474
:
[First]
[<<]
[5]
[6]
[7]
[8]
[9]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit